Skip to content
OpenCapital
Get started

iRadimed IRMD Q4 2025 Annual earnings

Reported February 10, 2026 · Before market open

Revenue$22.7MBeat by $1.1M
EPS$0.54Beat by $0.05
Revenue estimate$21.6M
EPS estimate$0.49

Next report

Jul 31, 2026 (In 2 days)
Revenue estimate$20.4M
EPS estimate$0.42

Financials

Q4 2025

Income statement

See full
Revenue$22.7M+17.0%
Gross profit$17.0M+15.4%
Operating income$7.1M+22.3%
Net income$6.4M+25.2%
EPS (diluted)$0.50+25.0%

Balance sheet

See full
Cash & equivalents$51.2M-2.1%
Total equity$94.6M+9.0%
Total assets$108.8M+10.6%

Cash flow

See full
Operating cash flow$5.9M-1.1%
CapEx$294.2K-89.5%
Free cash flow$5.6M+76.1%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.24B+77.5%
P/E55.1×+18.8×
P/S14.8×+5.2×

Profitability

See full
Gross margin76.7%-0.2pp
Operating margin31.2%+1.2pp
Net margin26.8%+0.6pp
FCF margin20.5%-3.6pp

Returns & leverage

See full
Return on equity24.8%+0.5pp
Current ratio8×-0.9×

Versus estimates

Revenue

Q1 2026$22.0MBeat by $664.0K
Q4 2025$22.7MBeat by $1.1M
Q3 2025$21.2MMiss by $394.9KQ2 2025$20.4MMiss by $89.1KQ1 2025$19.5MBeat by $178.6KQ4 2024$19.4MBeat by $189.2K

Diluted EPS

Q1 2026$0.49Beat by $0.03
Q4 2025$0.54Beat by $0.05
Q3 2025$0.47Miss by $0.01Q2 2025$0.49Beat by $0.04Q1 2025$0.42Miss by $0.01Q4 2024$0.44Miss by $0.01

Ask the moment iRadimed reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did iRadimed report Q4 2025 earnings?
iRadimed (IRMD) reported Q4 2025 earnings on February 10, 2026 before market open.
What were iRadimed's Q4 2025 revenue and EPS?
iRadimed reported revenue of $22.7M and eps of $0.54 for Q4 2025.
Did iRadimed beat estimates in Q4 2025?
Revenue beat the consensus estimate of $21.6M by $1.1M. EPS beat the consensus estimate of $0.49 by $0.05.
How did iRadimed's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 17.0% from $19.4M a year earlier and eps grew 22.7% from $0.44.
Where can I find iRadimed's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-012356) and the 10-K periodic report (0001104659-26-024691) directly on SEC EDGAR. The filing index links above go to sec.gov.